854 Shares in McKesson Corporation $MCK Purchased by WINTON GROUP Ltd

WINTON GROUP Ltd bought a new position in McKesson Corporation (NYSE:MCK) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 854 shares of the company’s stock, valued at approximately $701,000.

Other hedge funds also recently made changes to their positions in the company. GGM Financials LLC purchased a new stake in shares of McKesson in the third quarter worth about $25,000. State of Wyoming purchased a new stake in McKesson during the second quarter valued at approximately $29,000. Board of the Pension Protection Fund purchased a new stake in McKesson during the fourth quarter valued at approximately $33,000. Kingdom Financial Group LLC. purchased a new stake in McKesson during the fourth quarter valued at approximately $33,000. Finally, Vermillion & White Wealth Management Group LLC purchased a new stake in McKesson during the third quarter valued at approximately $33,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

MCK has been the topic of a number of recent research reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $875.00 price objective on shares of McKesson in a research report on Friday, May 8th. Barclays decreased their price objective on McKesson from $1,050.00 to $925.00 and set an “overweight” rating on the stock in a research report on Wednesday. William Blair initiated coverage on McKesson in a research report on Tuesday, April 28th. They set an “outperform” rating on the stock. Bank of America decreased their price objective on McKesson from $1,040.00 to $1,000.00 and set a “buy” rating on the stock in a research report on Monday, April 6th. Finally, Raymond James Financial set a $970.00 price objective on McKesson in a research report on Thursday, March 5th. Fourteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, McKesson has an average rating of “Moderate Buy” and an average price target of $960.53.

Insider Activity at McKesson

In other news, EVP Michele Lau sold 3,550 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total transaction of $2,701,869.50. Following the transaction, the executive vice president directly owned 3,247 shares of the company’s stock, valued at approximately $2,471,259.23. This trade represents a 52.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $764.00, for a total transaction of $101,612.00. Following the transaction, the chief accounting officer directly owned 632 shares in the company, valued at approximately $482,848. This trade represents a 17.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 6,893 shares of company stock worth $5,225,385 in the last quarter. 0.08% of the stock is owned by company insiders.

McKesson Stock Up 0.6%

MCK opened at $789.20 on Thursday. The business has a fifty day moving average of $801.42 and a 200 day moving average of $847.34. McKesson Corporation has a 52-week low of $637.00 and a 52-week high of $999.00. The stock has a market cap of $94.87 billion, a P/E ratio of 20.51, a PEG ratio of 1.29 and a beta of 0.31.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Thursday, May 7th. The company reported $11.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The company had revenue of $96.30 billion during the quarter, compared to analysts’ expectations of $101.35 billion. During the same quarter in the previous year, the business earned $10.12 EPS. McKesson’s revenue was up 6.0% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Equities analysts anticipate that McKesson Corporation will post 44.28 EPS for the current fiscal year.

McKesson Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, June 1st. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is presently 8.53%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.